Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,100 full-time employees. The firm's primary focus is products related to human health and well-being. The firm operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolism. Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, cardiovascular, and vision fields. These products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eyecare professionals, and clinics.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/29/2026
12/28/2025
09/28/2025
06/29/2025
03/30/2025
Revenue
96,362
24,062
24,564
23,993
23,743
21,893
Revenue Growth (YoY)
8%
10%
9%
7%
6%
2%
Cost of Revenue
30,887
8,071
7,912
7,291
7,613
7,349
Gross Profit
65,475
15,991
16,652
16,702
16,130
14,544
Selling, General & Admin
24,598
6,034
6,753
5,922
5,889
5,112
Research & Development
14,967
3,527
4,252
3,672
3,516
3,225
Operating Expenses
38,627
9,374
10,818
9,323
9,112
7,886
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
24,940
5,990
4,966
7,493
6,491
13,631
Income Tax Expense
3,900
755
-150
2,341
954
2,632
Net Income
21,040
5,235
5,116
5,152
5,537
10,999
Net Income Growth
-4%
-52%
49%
91%
18%
238%
Shares Outstanding (Diluted)
2,445.2
2,445.2
2,443.2
2,428.6
2,419.1
2,423.8
Shares Change (YoY)
1%
1%
1%
0%
0%
0%
EPS (Diluted)
8.6
2.14
2.09
2.12
2.29
4.54
EPS Growth
-4%
-53%
48%
91%
19%
239%
Free Cash Flow
--
--
5,472
8,012
2,835
3,379
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
67.94%
66.45%
67.79%
69.61%
67.93%
66.43%
Operating Margin
27.86%
27.49%
23.75%
30.75%
29.55%
30.41%
Profit Margin
21.83%
21.75%
20.82%
21.47%
23.32%
50.23%
Free Cash Flow Margin
--
--
22.27%
33.39%
11.94%
15.43%
EBITDA
--
--
7,845
9,156
8,961
8,430
EBITDA Margin
--
--
31.93%
38.16%
37.74%
38.5%
D&A For EBITDA
--
--
2,011
1,777
1,943
1,772
EBIT
26,848
6,617
5,834
7,379
7,018
6,658
EBIT Margin
27.86%
27.49%
23.75%
30.75%
29.55%
30.41%
Effective Tax Rate
15.63%
12.6%
-3.02%
31.24%
14.69%
19.3%
Follow-Up Questions
What are Johnson & Johnson's key financial statements?
According to the latest financial statement (Form-10K), Johnson & Johnson has a total asset of $0, Net loss of $0
What are the key financial ratios for JNJ?
Johnson & Johnson's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Johnson & Johnson's revenue broken down by segment or geography?
Johnson & Johnson largest revenue segment is Consumer Health, at a revenue of 14,953,000,000 in the most earnings release.For geography, United States is the primary market for Johnson & Johnson, at a revenue of 53,752,000,000.
Is Johnson & Johnson profitable?
no, according to the latest financial statements, Johnson & Johnson has a net loss of $0
Does Johnson & Johnson have any liabilities?
no, Johnson & Johnson has liability of 0
How many outstanding shares for Johnson & Johnson?
Johnson & Johnson has a total outstanding shares of 0